ArticlePakistan journal of medical sciences2025
Comparison of IV Nalbuphine versus ibuprofen for Postoperative Pain control in cesarean section.
Article in Pakistan journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06594224 (Comparison of IV Nalbuphine Versus Ibuprofen for Postoperative Pain Control in Cesarean Section), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Comparison of IV Nalbuphine Versus Ibuprofen for Postoperative Pain Control in Cesarean Section
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the effectiveness of intravenous (IV) nalbuphine versus IV ibuprofen for postoperative pain relief following cesarean section under general anaesthesia. Methodology: This randomized controlled trial was conducted at the department of obstetrics and gynecology, Nishtar Hospital, Multan, Pakistan from March 2024 to August 2024. A total of 80 females, aged between 18-45 years, gestational age above 32 weeks, body mass index (BMI) ≤ 30 kg/m Results: Post-operatively, the Nalbuphine group showed better pain control than the Ibuprofen group at one hour (p<0.001), three hours (p<0.001), and six hours (p=0.011). Rescue analgesia was required more frequently in the Ibuprofen group (70.0% vs. 17.5%, p<0.001). Patient satisfaction was higher in the Nalbuphine group (62.5% vs. 12.5%, p<0.001). Nausea (20.0% vs. 10.0%, p=0.210), and gastrointestinal discomfort (2.5% vs. 12.5%, p=0.090) were statistically similar. Drowsiness was more frequent with Nalbuphine group (25.0% vs. 5.0%, p=0.012). Conclusion: This study demonstrated that IV Nalbuphine was more effective than IV Ibuprofen for postoperative pain relief following cesarean section under general anesthesia. Nalbuphine provided superior pain control, reduced the need for rescue analgesia, and resulted in higher patient satisfaction. Trial Registration: Trial registration at clinicaltrials.gov as NCT06594224.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.